HilleVax, Inc. (HLVX) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 54 transactions totaling $32.7M, demonstrating a bullish sentiment with $27.5M in net insider flow. The most recent transaction on Sep 17, 2025 involved a transaction of 83,738 shares valued at $0.
No significant insider buying has been recorded for HLVX in the recent period.
No significant insider selling has been recorded for HLVX in the recent period.
Based on recent SEC filings, insider sentiment for HLVX is bullish with an Insider Alignment Score of 92/100 and a net flow of $27.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HilleVax, Inc. (HLVX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading HLVX stock, having executed 54 transactions in the past 90 days. The most active insider is James N. Topper (Executive), who has made 4 transactions totaling $83.9M.
Get notified when executives and directors at HLVX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Maltbie Shane | Executive | Tender | 83,738 | $N/A | $0 | |
| Sep 17, 2025 | L. Gerberding Julie | Executive | Tender | 59,224 | $N/A | $0 | |
| Sep 17, 2025 | Dubin Gary | Executive | Tender | 17,199 | $N/A | $0 | |
| Sep 17, 2025 | Kohli Aditya | Executive | Tender | 698,171 | $N/A | $0 | |
| Sep 17, 2025 | L. Hilleman Jeryl | Executive | Tender | 59,224 | $N/A | $0 | |
| Sep 17, 2025 | Chu Shelley | Executive | Tender | 17,199 | $N/A | $0 | |
| Sep 17, 2025 | Cocero Nanette | Executive | Tender | 17,199 | $N/A | $0 | |
| Sep 17, 2025 | Hershberg Robert | Executive | Tender | 1,101,498 | $N/A | $0 | |
| Sep 17, 2025 | Sepulveda Jaime | Executive | Tender | 59,224 | $N/A | $0 | |
| Sep 17, 2025 | N. Topper James | Executive | Tender | 17,199 | $1.95 | $33.5K | |
| Sep 17, 2025 | N. Topper James | Executive | Tender | 8,535,337 | $1.95 | $16.6M | Large |
| Sep 17, 2025 | Co Ltd Takeda Pharmaceutical | Executive | Tender | 6,724,000 | $1.95 | $13.1M | Large |
| May 22, 2024 | Kohli Aditya | Executive | Sale | 6,000 | $14.73 | $88.4K | 10b5-1 |
| May 21, 2024 | Kohli Aditya | Executive | Sale | 6,000 | $14.21 | $85.3K | 10b5-1 |
| May 20, 2024 | Kohli Aditya | Executive | Sale | 6,000 | $15.45 | $92.7K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 1 | $37.2M | 37.2% |
Purchase(P) | 3 | $30.1M | 30.2% |
Tender(U) | 12 | $29.8M | 29.8% |
Sale(S) | 28 | $2.6M | 2.6% |
Disposition(D) | 1 | $161.1K | 0.2% |
Award(A) | 8 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Insiders at HilleVax, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 54 transactions totaling $30.1M in purchases versus $2.6M in sales, the net buying activity of $27.5M signals strong executive confidence. James N. Topper (Executive) leads the buying activity with $83.9M in transactions across all time.